James Ferrara, MD, Hematology, New York, NY, Mount Sinai Hospital

JamesL MFerraraMD

Hematology New York, NY

Hematologic Oncology

Professor and Director of Hematologic Malignancies Translational Research Center

Dr. Ferrara is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ferrara's full profile

Already have an account?

Education & Training

  • Oxford UniversityOTHER_TRAINING
  • Boston Children's Hospital
    Boston Children's HospitalFELLOWSHIP
  • Boston Children's Hospital
    Boston Children's HospitalRESIDENCY
  • Boston Children's Hospital
    Boston Children's HospitalINTERNSHIP
  • Georgetown University
    Georgetown UniversityOTHER_TRAINING
  • Georgetown University School of Medicine
    Georgetown University School of MedicineMEDICAL_SCHOOL
  • Oxford UniversityOTHER_TRAINING
  • Xavier UniversityOTHER_TRAINING

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2015 - 2022
  • MI State Medical License
    MI State Medical License 1998 - 2015

Awards, Honors, & Recognition

  • Ward-Coleman Chair in Cancer Medicine Icahn School of Medicine, 2014
  • Nobel Lecture Karolinska Institutet, Stockholm, Sweden, 2012
  • E. Donnell Thomas Lecturer ASBMT, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft versus host disease.  
    Sakamoto H, Michaelson J, Jones WK, Bhan AK, Abhyankar S, Silverstein M, Golan DE, Burakoff SJ, Ferrara JLM, P Natl Acad Sci USA
  • The effect of donor T lymphocytes and total body irradiation on hematopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transpla...  
    Down JD, Mauch P, Warhol M, Neben S, Ferrara JLM, Transplantation
  • Cytokine dysregulation and acute graft versus host disease.  
    Antin JH and Ferrara JLM, Blood
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
    James L. M. Ferrara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • The Evolving Treatment Landscape for Patients with GvHD: More Options, More Decisions, Better Outcomes! 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Reining in Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • Reining in Graft-Versus-Host Disease (GVHD) After Allogeneic Hematopoietic Cell Transplantation 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Join now to see all

Other

Press Mentions

  • Expert Discusses Approval of First CAR T-cell Therapy
    Expert Discusses Approval of First CAR T-cell Therapy
  • Novartis, Juno Face Production Hurdles for New Blood Cancer Drugs
    Novartis, Juno Face Production Hurdles for New Blood Cancer Drugs

Professional Memberships

Hospital Affiliations